Jazz Pharmaceuticals plc buy Cantor Fitzgerald
Start price
22.03.24
/
50%
€113.00
Target price
22.03.25
€166.54
Performance (%)
-9.47%
Price
26.04.24
€102.30
Summary
This prediction is currently active. With a performance of -9.47%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 22.03.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | -0.872% | -0.872% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€106.15
10.04.24
10.04.24
€167.24
10.04.25
10.04.25
-3.63%
26.04.24
26.04.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.90
29.02.24
29.02.24
€166.54
28.02.25
28.02.25
-6.92%
26.04.24
26.04.24